OTLK Outlook Therapeutics, Inc.

Oncobiologics Inc is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology.

$2.35  +0.01 (0.43%)
As of 06/23/2021 15:59:41 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  06/14/2016
Outstanding shares:  173,605,807
Average volume:  850,618
Market cap:   $425,334,227
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    69012T107
ISIN:        
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   19.66
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%